Resultados de la búsqueda 441-450 of 12105 for 6-Month Checkup
... 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke. A Study for Cerebral Open Flow ...
... month. Investigation Of Ubamatamab Combination Therapy In Adult Participants ... Ir a página 66 · Ir a página 77 · Ir a página 88 · SiguientePróxima página.
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...
Treatment Resistant Depression Subcallosal Cingulate Network ... Rochester, Minn. The purpose of this study is to evaluate the effectiveness and safety of ...
The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, and ...
... 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke. A Study to Review Magnetic Resonance ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?